$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| AZN: 1ST QUARTER RESULTS | 29 Apr 2016 |
| NOTICE OF RESULTS | 28 Apr 2016 |
| BEVESPI AEROSPHERE APPROVED BY US FDA FOR COPD | 26 Apr 2016 |
| AZ ENTERS US LICENSING AGREEMENT WITH IRONWOOD | 26 Apr 2016 |
| AZ TO CONTINUE PIVOTAL ALZHEIMER'S CLINICAL TRIAL | 08 Apr 2016 |
| TOTAL VOTING RIGHTS | 01 Apr 2016 |
| TAGRISSO APPROVED IN JAPAN FOR CANCER PATIENTS | 29 Mar 2016 |
| DIRECTOR/PDMR SHAREHOLDING | 24 Mar 2016 |
| AZ REPORTS RESULTS FROM BRILINTA STROKE TRIAL | 23 Mar 2016 |
| NOTICE OF AGM | 18 Mar 2016 |
| 6-K | 18 Mar 2016 |
| FILING OF FORM 20-F WITH SEC | 08 Mar 2016 |
| ANNUAL FINANCIAL REPORT | 08 Mar 2016 |
| TOTAL VOTING RIGHTS | 01 Mar 2016 |
| AZ REPORTS TOP-LINE RESULT OF TREMELIMUMAB TRIAL | 29 Feb 2016 |
| AZ ENTERS LICENSING AGREEMENT WITH CMS FOR PLENDIL | 29 Feb 2016 |
| DIRECTOR/PDMR SHAREHOLDING | 26 Feb 2016 |
| ACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED | 25 Feb 2016 |
| BRILIQUE APPROVED IN EU FOR HEART ATTACK PATIENTS | 19 Feb 2016 |
| ZURAMPIC APPROVED IN EU FOR GOUT PATIENTS | 19 Feb 2016 |
